ArticleTrials2021

IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis.

N Vergis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.